Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Receivables (2016 - 2025)

INVO Fertility has reported Receivables over the past 16 years, most recently at $274200.0 for Q3 2025.

  • Quarterly Receivables rose 6.67% to $274200.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $274200.0 through Sep 2025, up 6.67% year-over-year, with the annual reading at $174881.0 for FY2024, 24.43% up from the prior year.
  • Receivables was $274200.0 for Q3 2025 at INVO Fertility, up from $242255.0 in the prior quarter.
  • Over five years, Receivables peaked at $807811.0 in Q1 2021 and troughed at $16310.0 in Q4 2021.
  • The 5-year median for Receivables is $74908.0 (2023), against an average of $146008.5.
  • Year-over-year, Receivables surged 21738.63% in 2021 and then plummeted 92.73% in 2022.
  • A 5-year view of Receivables shows it stood at $16310.0 in 2021, then soared by 373.02% to $77149.0 in 2022, then skyrocketed by 82.18% to $140550.0 in 2023, then rose by 24.43% to $174881.0 in 2024, then surged by 56.79% to $274200.0 in 2025.
  • Per Business Quant, the three most recent readings for IVF's Receivables are $274200.0 (Q3 2025), $242255.0 (Q2 2025), and $173614.0 (Q1 2025).